FDA Orange Book · active-ingredient family
Indomethacin
Indomethacin: 12 brands, 59 generics; first approved Feb 23, 1982; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 59 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
12
Generics (ANDA)
59
Listed patents
3
Next patent expiry
Apr 23, 2030
in 3 yr 7 mo
Brand (NDA) products
Originator applications
- TIVORBEXRLDGENUSNDA 20476820142 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 20MG CAPSULE ORAL Discontinued - 40MG CAPSULE ORAL Discontinued - - INDOMETHACINRLDRSFRESENIUS KABI USANDA 0225362010
Approved strengths under this FDA application. Strength Dosage form Route Status TE EQ 1MG BASE/VIAL INJECTABLE INJECTION Rx - - COSETTENDA 0183321985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG/5ML SUSPENSION ORAL Rx AB - INDOCINRLDCOSETTENDA 0178141984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG SUPPOSITORY RECTAL Discontinued - - INDOCIN SRRLDZYLANDA 0181851982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOCINRLDZYLA LIFE SCIENCESNDA 016059-2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINPARKE DAVISNDA 01880619842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINCHARTWELL MOLECULESNDA 01882919842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Rx AB 25MG CAPSULE ORAL Rx AB - INDOMETHACINWATSON LABSNDA 01869019842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINHERITAGENDA 01885119842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINIVAX SUB TEVA PHARMSNDA 01873019842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINRISINGNDA 01885819842 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued -
Generic (ANDA) products (59)
Abbreviated applications
- INDOMETHACINANNORA PHARMAANDA 2169052025
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG SUPPOSITORY RECTAL Rx AB - INDOMETHACINAMNEALANDA 2153992025
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG SUPPOSITORY RECTAL Rx AB - INDOMETHACINHIKMAANDA 2158992024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG SUPPOSITORY RECTAL Rx AB - INDOMETHACINNOVITIUM PHARMAANDA 2178832024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG/5ML SUSPENSION ORAL Rx AB - INDOMETHACINZYDUS LIFESCIENCESANDA 2161842023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG SUPPOSITORY RECTAL Rx AB - INDOMETHACINZYDUS PHARMSANDA 2027112017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB - INDOMETHACINJUBILANT GENERICSANDA 20521520172 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINGLENMARK PHARMS LTDANDA 2035012017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB - INDOMETHACINNOVAST LABSANDA 2048532017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB - INDOMETHACINAUROBINDO PHARMAANDA 2042432016
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOMETHACINJUBILANT GENERICSANDA 2027062015
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOMETHACINMYLANANDA 2021392014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOMETHACINWATSON LABS INCANDA 2025722013
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOMETHACINSUN PHARM INDS INCANDA 09140120132 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINRSHETERO LABS LTD IIIANDA 2018072012
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB - INDOMETHACINHETERO LABS LTD IIIANDA 09124020112 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB - INDOMETHACINGLENMARK PHARMS LTDANDA 09127620102 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB - INDOMETHACINAMNEAL PHARMSANDA 0915492010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB - INDOMETHACINCHARTWELL RXANDA 2005292010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB - INDOMETHACINZYDUS LIFESCIENCESANDA 09040320102 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB 50MG CAPSULE ORAL Rx AB - INDOMETHACINAVANTHI INCANDA 0791752009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Rx AB - INDOMETHACINABLEANDA 07666620032 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - 50MG CAPSULE ORAL Discontinued - - INDOMETHACINABLEANDA 0761142002
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOMETHACINSANDOZANDA 0744641998
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOMETHACINRSCOSETTEANDA 0733141992
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG SUPPOSITORY RECTAL Rx AB - INDOMETHACINWATSON LABSANDA 0729961991
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINWATSON LABSANDA 0729971991
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACININWOOD LABSANDA 0724101989
Approved strengths under this FDA application. Strength Dosage form Route Status TE 75MG CAPSULE, EXTENDED RELEASE ORAL Discontinued - - INDOMETHACINTEVAANDA 0713421988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINTEVAANDA 0713431988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINHALSEYANDA 0707821987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINHALSEYANDA 0706351987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINWATSON LABSANDA 0716351987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINSANDOZANDA 0706731987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Rx AB - INDOMETHACINSANDOZANDA 0706741987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Rx AB - INDOMETHACINANI PHARMSANDA 0711481987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINANI PHARMSANDA 0711491987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINHIKMAANDA 0714121987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG/5ML SUSPENSION ORAL Discontinued - - INDOMETHACINSUN PHARM INDUSTRIESANDA 07090019872 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - 25MG CAPSULE ORAL Discontinued - - INDOMETHACINSUPERPHARMANDA 0704871986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINSUPERPHARMANDA 0704881986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINMUTUAL PHARMANDA 0700671986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINMUTUAL PHARMANDA 0700681986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINWATSON LABSANDA 0707841986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINWATSON LABSANDA 0707851986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINPIONEER PHARMSANDA 0708131986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINPIONEER PHARMSANDA 0705921986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINCHARTWELL MOLECULESANDA 0706511986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Rx AB - INDOMETHACINHERITAGE PHARMAANDA 0707191986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINHERITAGE PHARMAANDA 0707561986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - TEVAANDA 0702661985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - TEVAANDA 0702671985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINDURAMED PHARMS BARRANDA 0703261985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINDURAMED PHARMS BARRANDA 0703271985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINWATSON LABSANDA 0705291985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINWATSON LABSANDA 0705301985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINRISINGANDA 0706241985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued - - INDOMETHACINCYCLEANDA 0703531985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 25MG CAPSULE ORAL Discontinued - - INDOMETHACINCYCLEANDA 0703541985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 50MG CAPSULE ORAL Discontinued -
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 9089471 | in 3 yr 7 mo | U-55 | |
| 8734847 | in 3 yr 7 mo | Product | |
| 8992982 | in 3 yr 7 mo | Product |
Approval history
FDA approval span
First approval
45 yr 4 mo ago
Most recent approval
1 yr 4 mo ago
Approvals span 1982–2025 across 71 FDA applications.
Brand (NDA) 1217%
Generic (ANDA) 5983%
Indomethacin: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.
Assyro Intelligence
Ask anything about Indomethacin
Cited answers from FDA, EMA, Health Canada, PubMed and ClinicalTrials.gov, in seconds. Free, no sign-up.
Evaluating for a team? Book a demo